CN112384240B - 糖缀合物疫苗 - Google Patents
糖缀合物疫苗 Download PDFInfo
- Publication number
- CN112384240B CN112384240B CN201980029219.5A CN201980029219A CN112384240B CN 112384240 B CN112384240 B CN 112384240B CN 201980029219 A CN201980029219 A CN 201980029219A CN 112384240 B CN112384240 B CN 112384240B
- Authority
- CN
- China
- Prior art keywords
- streptococcus pneumoniae
- protein
- vaccine
- capsular
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202411403758.XA CN119454925A (zh) | 2018-05-03 | 2019-05-02 | 糖缀合物疫苗 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1807303.1 | 2018-05-03 | ||
| GBGB1807303.1A GB201807303D0 (en) | 2018-05-03 | 2018-05-03 | Glyconjugate vaccines |
| PCT/EP2019/061266 WO2019211386A1 (en) | 2018-05-03 | 2019-05-02 | Glyconjugate vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202411403758.XA Division CN119454925A (zh) | 2018-05-03 | 2019-05-02 | 糖缀合物疫苗 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112384240A CN112384240A (zh) | 2021-02-19 |
| CN112384240B true CN112384240B (zh) | 2024-10-29 |
Family
ID=62598278
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980029219.5A Active CN112384240B (zh) | 2018-05-03 | 2019-05-02 | 糖缀合物疫苗 |
| CN202411403758.XA Pending CN119454925A (zh) | 2018-05-03 | 2019-05-02 | 糖缀合物疫苗 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202411403758.XA Pending CN119454925A (zh) | 2018-05-03 | 2019-05-02 | 糖缀合物疫苗 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12048743B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3787675A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7511188B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN112384240B (cg-RX-API-DMAC7.html) |
| GB (1) | GB201807303D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019211386A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4748391A1 (en) * | 2024-11-20 | 2026-05-27 | MinervaX ApS | N-terminal region of a group b streptococcus surface protein as a carrier for the capsular polysaccharide |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017216286A1 (en) * | 2016-06-17 | 2017-12-21 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| NZ230747A (en) | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
| WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| SE0202110D0 (sv) | 2002-07-05 | 2002-07-05 | Isconova Ab | Iscom preparation and use thereof |
| SE0301998D0 (sv) | 2003-07-07 | 2003-07-07 | Isconova Ab | Quil A fraction with low toxicity and use thereof |
| GB0421083D0 (en) * | 2004-09-22 | 2004-10-27 | Glaxosmithkline Biolog Sa | Purification process |
| SI2257307T1 (sl) | 2008-02-20 | 2018-09-28 | Glaxosmithkline Biologicals S.A. | Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic |
| US20120135037A1 (en) | 2009-06-01 | 2012-05-31 | Mizel Steven B | Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same |
| CN103533954B (zh) | 2011-03-02 | 2015-09-09 | 诺华股份有限公司 | 含较低剂量的抗原和/或佐剂的联合疫苗 |
| US9040057B2 (en) | 2011-09-25 | 2015-05-26 | Chang Gung Medical Foundation, Linkou Branch | Method of diagnosing and preventing pneumococcal diseases using pneumococcal neuraminidases |
| WO2013131983A1 (en) * | 2012-03-07 | 2013-09-12 | Novartis Ag | Adjuvanted formulations of streptococcus pneumoniae antigens |
| GB201301085D0 (en) | 2013-01-22 | 2013-03-06 | London School Hygiene & Tropical Medicine | Glycoconjugate Vaccine |
| EP4272750A3 (en) * | 2013-02-07 | 2024-01-24 | Children's Medical Center, Corp. | Protein antigens that provide protection against pneumococcal colonization and/or disease |
-
2018
- 2018-05-03 GB GBGB1807303.1A patent/GB201807303D0/en not_active Ceased
-
2019
- 2019-05-02 US US17/052,485 patent/US12048743B2/en active Active
- 2019-05-02 CN CN201980029219.5A patent/CN112384240B/zh active Active
- 2019-05-02 CN CN202411403758.XA patent/CN119454925A/zh active Pending
- 2019-05-02 WO PCT/EP2019/061266 patent/WO2019211386A1/en not_active Ceased
- 2019-05-02 EP EP19729443.2A patent/EP3787675A1/en active Pending
- 2019-05-02 JP JP2021510540A patent/JP7511188B2/ja active Active
-
2024
- 2024-01-11 JP JP2024002863A patent/JP7833736B2/ja active Active
- 2024-06-13 US US18/742,842 patent/US12472249B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017216286A1 (en) * | 2016-06-17 | 2017-12-21 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
Non-Patent Citations (1)
| Title |
|---|
| Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection;Jeremy S. Brown等;Infect Immun;20011231;第69卷(第11期);摘要,第6704页右栏第2段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB201807303D0 (en) | 2018-06-20 |
| CN112384240A (zh) | 2021-02-19 |
| JP2021526547A (ja) | 2021-10-07 |
| CN119454925A (zh) | 2025-02-18 |
| EP3787675A1 (en) | 2021-03-10 |
| WO2019211386A1 (en) | 2019-11-07 |
| US12472249B2 (en) | 2025-11-18 |
| US20230241208A1 (en) | 2023-08-03 |
| JP7511188B2 (ja) | 2024-07-05 |
| US12048743B2 (en) | 2024-07-30 |
| JP2024041903A (ja) | 2024-03-27 |
| JP7833736B2 (ja) | 2026-03-23 |
| US20240382585A1 (en) | 2024-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11572391B2 (en) | Antibodies for prevention, treatment and diagnosis of P. gingivalis infection | |
| US7960535B2 (en) | Recombinant lipidated PsaA protein, methods of preparation and use | |
| CN101855238B (zh) | 融合蛋白疫苗 | |
| US11484584B2 (en) | Immunogenic complex for eliciting protective immunity against group B Streptococcus | |
| US20180256698A1 (en) | Proline-rich peptides protective against s. pneumoniae | |
| JP2021528059A (ja) | グリコシル化されたComPピリンバリアント、製造方法及びその使用 | |
| CN112153980A (zh) | 包含葡萄球菌抗原的免疫原性组合物 | |
| US7255863B2 (en) | Group A streptococcal vaccines | |
| CN113164580A (zh) | 肺炎球菌融合蛋白疫苗 | |
| WO2009143413A1 (en) | Synergistic immunogenic fusion protein-polysaccharide conjugate | |
| JP2017160238A (ja) | ストレプトコッカス・ニューモニエ(Streptococcus pneumoniae)に対する融合抗原ワクチンおよび組成物 | |
| US12472249B2 (en) | Glyconjugate vaccines | |
| CN102488898B (zh) | 龋齿疫苗及制备方法 | |
| WO2018009906A1 (en) | Whole cell-protein conjugates and methods of making the same | |
| JP2018522978A (ja) | 免疫原性組成物 | |
| CA3079111A1 (en) | Comprehensive vaccine design for commensal disease progression | |
| US8691243B2 (en) | Protein-based Streptococcus pneumoniae vaccine | |
| HK40079037A (zh) | 脑膜炎奈瑟氏球菌疫苗及其应用 | |
| WO2024081906A1 (en) | A maps vaccine targeting group b streptococcus (gbs) | |
| HK1250933A1 (en) | Immunogenic fusion protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |